Similar findings with respect to endothelium-dependent dilatation, CNP responsiveness, and vasoconstrictor activity were observed in portal veins from CCl4-treated WT mice with hepatic fibrosis (Fig. S4A–E). This evidence concerns the gene CNP and Hepatic fibrosis.